Scientist @ UCM. @DanaFarber/@HarvardMed Alumni. Passionate about #cancer immunology, #immunotherapy & what the gut #microbiome has to do with it
Joined September 2013
- Tweets10.6K
- Following1.2K
- Followers2.2K
- Likes138
Matthias Piesche retweeted
Primera reunión de la mesa macrozonal de #cáncer q cuenta c/la participación de investigadores e investigadoras de la @ucatolicamaule @PiescheLab @facmedicinaucm
¡¡Comenzamos!! La primera sesión de la Mesa Macrozonal de Cáncer, organizada por la @SeremiCienciaCS y @nodoctci, instancia que permitirá generar alianzas interinstitucionales para la creación de un Consorcio Científico en la Macrozona Centro Sur.
Matthias Piesche retweeted
"These data demonstrate that MVA-S vaccination confers a complete protection against #SARSCoV2 brain infection and the associated neuropathological damage (neuronal loss and vascular damage), even after a second viral infection."
nature.com/articles/s41593-0…
@NatureNeuro @ibis_sevilla
Matthias Piesche retweeted
Felicitaciones a los nuevos proyectos #FIC #Maule. @ucatolicamaule obtuvo 4 proyectos en biopackaging, #cáncer gástrico, #AI en #riego, #labmovil. @PiescheLab @facmedicinaucm – at Talca, Chile
Matthias Piesche retweeted
Integrin/TGF-β1 inhibitors highly effective in attenuating COVID-19 severity news-medical.net/news/202201… @medrxivpreprint @BrownUniversity #COVID19 #Severecovid #Coronavirus #SARSCoV2
Matthias Piesche retweeted
Integrin/TGF-β1 inhibitors highly effective in attenuating COVID-19 severity (pre-print)
news-medical.net/news/202201…
Matthias Piesche retweeted
Happy to share collaborative paper between #eldeirylab @BrownUCancer @PiescheLab Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity mdpi.com/1424-8247/15/5/618
Matthias Piesche retweeted
An overall 40% improvement of symptoms of #LongCovid by 2-dose vaccination
link.springer.com/article/10… with dose-response, among ~1,600 symptomatic people as self-reported, adjusted for comorbidities, by @mayssamnehme @Hopitaux_unige @LongCovidCH and colleagues
Matthias Piesche retweeted
Cardiotoxicity💔of immune checkpoint inhibitors is a rare but possibly fatal complication🚨‼️Increasing awareness and further investigation are needed🔎 Now out in BJMO our review👇🏻 #Immunotherapy #CardioTwitter @E_de_Azambuja @mybsmo
bjmo.be/journal-article/card…
Matthias Piesche retweeted
One person in the UK has died with Omicron variant of coronavirus, Prime Minister Boris Johnson confirms bbc.in/3lWRT8o
Matthias Piesche retweeted
Unfavorable Long-Term Trends in the Age of Principal Investigators Supported for the First Time on NIH R01-Equivalent Awards – NIH Extramural Nexus nexus.od.nih.gov/all/2021/11…
Matthias Piesche retweeted
Con los estudiantes estamos preparando una mini celebración #premios nobel. #ionchannels para todos. 10 Nov. 17.00 h. Poster hecho por la tesista Sofía🤩🤓
Matthias Piesche retweeted
Thanks to Frontiers.org for their compendium as an e-book of our research-reviewing of Eicosanoids in Cancer frontiersin.org/research-top… and @piescheLab
Matthias Piesche retweeted
Martes 13, 18:00 h Charla Magistral UCM Dra. Ma. Eugenia Gómez-Casati @Maru21665051 🇦🇷 @UBAonline. "Pérdida de audición x ruidos y envejecimiento". #ciencia con directa relación en clínica🔬👂🦻 #FacebookLive @ucatolicamaule
Matthias Piesche retweeted
Addition of #Pembrolizumab to #Trastuzumab Plus Chemotherapy Improves Response in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Cancer
@YJanjigianMD #ASCO21 dailynews.ascopubs.org/do/10…
Matthias Piesche retweeted
#ASCO21
Another great talk by #ctDNA guru @max_diehn where he highlight
- ctDNA clearance assoc with improved outcomes from consolidation IO in stage III NSCLC
- improving background detection rate may improve false neg rates of ctDNA detection
@OncoAlert
#LCSM
Matthias Piesche retweeted
How can we identify upfront which TNBC patients will present a brain relapse? 5 letters: ctDNA❗️
#ASCO21 Abstract 507 - among 323 TNBC patients, nearly all of those with detectable CSF-ctDNA developed brain mets, whereas only 1% in the ctDNA- group relapsed in the brain – at Milan, Lombardy
Matthias Piesche retweeted
La inequidad en Chile todos los niveles... y después dicen que no lo vieron venir...
👇👇👇
Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile science.sciencemag.org/conte…
Matthias Piesche retweeted
In @SciImmunology: Researchers show that one dose of mRNA #COVID19 #vaccine induces optimal antibody and #Bcell responses in previously infected people. Two doses are needed for immunologically naïve people. fcld.ly/27nby35 #WeekendReads